-

GDHG Shareholders With Large Losses Should Contact Securities Law Firm Robbins LLP for Information About Their Rights and Remedies Against Golden Heaven Group Holdings Ltd.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) securities between April 13, 2023 and November 13, 2023. Golden Heaven has stated that it “manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. [. . .]"

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: Golden Heaven Group Holdings Ltd. (GDHG) Misled Investors Regarding the Viability of its Amusement Parks

According to the complaint, during the class period, defendants failed to disclose that (1) Golden Heaven’s amusement parks are in generally poor condition, and (2) Golden Heaven materially overstated the number of visitors to its amusement parks and overall growth prospects. When the truth of the parks' condition was disclosed, the price of Golden Heaven stock declined by $6.63 per share, or 27.9%, to close at $17.12 on November 13, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Golden Heaven Holdings Ltd. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their lead plaintiff papers by February 20, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Golden Heaven Holdings Ltd. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:GDHG

Release Summary
Golden Heaven Group Holdings Ltd. (GDHG) misled investors regarding the viability of its amusement parks.
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Ostin Technology Group Co., Ltd. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ostin Technology Group Co., Ltd. (NASDAQ: OST) ordinary shares between May 11, 2025 and June 26, 2025. Ostin purports to be a manufacturer of thin-film transistor liquid crystal display modules and polarizers used in consumer electronics, commercial LCD displays, and automotive displays. For more information, submit a form, email attorney Aaro...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...
Back to Newsroom